Lentilactobacillus senioris DSM 24302 is a microaerophile, mesophilic, Gram-positive prokaryote that was isolated from feces of a healthy 100-year-old Japanese female.
Gram-positive rod-shaped microaerophile mesophilic genome sequence 16S sequence| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Lactobacillales |
| Family Lactobacillaceae |
| Genus Lentilactobacillus |
| Species Lentilactobacillus senioris |
| Full scientific name Lentilactobacillus senioris (Oki et al. 2012) Zheng et al. 2020 |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 17627 | MRS MEDIUM (DSMZ Medium 11) | Medium recipe at MediaDive | Name: MRS MEDIUM (DSMZ Medium 11) Composition: Glucose 20.0 g/l Casein peptone 10.0 g/l Meat extract 10.0 g/l Na-acetate 5.0 g/l Yeast extract 5.0 g/l (NH4)3 citrate 2.0 g/l K2HPO4 2.0 g/l Tween 80 1.0 g/l MgSO4 x 7 H2O 0.2 g/l MnSO4 x H2O 0.05 g/l Distilled water |
| @ref | Murein short key | Type | |
|---|---|---|---|
| 17627 | A11.31 | A4alpha L-Lys-D-Asp |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68371 | 18305 ChEBI | arbutin | - | builds acid from | from API 50CH acid |
| 68371 | 17057 ChEBI | cellobiose | - | builds acid from | from API 50CH acid |
| 68371 | 17108 ChEBI | D-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 15824 ChEBI | D-fructose | + | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 12936 ChEBI | D-galactose | - | builds acid from | from API 50CH acid |
| 68371 | 17634 ChEBI | D-glucose | + | builds acid from | from API 50CH acid |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68371 | 16899 ChEBI | D-mannitol | - | builds acid from | from API 50CH acid |
| 68371 | 16988 ChEBI | D-ribose | + | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | - | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68371 | 65327 ChEBI | D-xylose | + | builds acid from | from API 50CH acid |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 68371 | 4853 ChEBI | esculin | - | builds acid from | from API 50CH acid |
| 30248 | 28757 ChEBI | fructose | + | carbon source | |
| 68371 | 16813 ChEBI | galactitol | - | builds acid from | from API 50CH acid |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 30248 | 24265 ChEBI | gluconate | + | carbon source | |
| 68371 | 17754 ChEBI | glycerol | - | builds acid from | from API 50CH acid |
| 68371 | 28087 ChEBI | glycogen | - | builds acid from | from API 50CH acid |
| 68371 | 15443 ChEBI | inulin | - | builds acid from | from API 50CH acid |
| 68371 | 30849 ChEBI | L-arabinose | + | builds acid from | from API 50CH acid |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 18287 ChEBI | L-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 50CH acid |
| 68371 | 17266 ChEBI | L-sorbose | - | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17716 ChEBI | lactose | - | builds acid from | from API 50CH acid |
| 68371 | 17306 ChEBI | maltose | - | builds acid from | from API 50CH acid |
| 68371 | 6731 ChEBI | melezitose | - | builds acid from | from API 50CH acid |
| 68371 | 28053 ChEBI | melibiose | - | builds acid from | from API 50CH acid |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 17268 ChEBI | myo-inositol | - | builds acid from | from API 50CH acid |
| 30248 | 506227 ChEBI | N-acetylglucosamine | + | carbon source | |
| 68371 | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | Potassium 5-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | 16634 ChEBI | raffinose | - | builds acid from | from API 50CH acid |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 68371 | 17814 ChEBI | salicin | - | builds acid from | from API 50CH acid |
| 68371 | 28017 ChEBI | starch | - | builds acid from | from API 50CH acid |
| 68371 | 17992 ChEBI | sucrose | - | builds acid from | from API 50CH acid |
| 68371 | 27082 ChEBI | trehalose | - | builds acid from | from API 50CH acid |
| 68371 | 32528 ChEBI | turanose | - | builds acid from | from API 50CH acid |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | pathway | enzyme coverage | annotated reactions | external links | |
|---|---|---|---|---|---|
| 66794 | teichoic acid biosynthesis | 100 | 1 of 1 | ||
| 66794 | acetate fermentation | 100 | 4 of 4 | ||
| 66794 | ppGpp biosynthesis | 100 | 4 of 4 | ||
| 66794 | folate polyglutamylation | 100 | 1 of 1 | ||
| 66794 | UDP-GlcNAc biosynthesis | 100 | 3 of 3 | ||
| 66794 | coenzyme A metabolism | 100 | 4 of 4 | ||
| 66794 | CDP-diacylglycerol biosynthesis | 100 | 2 of 2 | ||
| 66794 | aspartate and asparagine metabolism | 88.89 | 8 of 9 | ||
| 66794 | vitamin B1 metabolism | 84.62 | 11 of 13 | ||
| 66794 | palmitate biosynthesis | 81.82 | 18 of 22 | ||
| 66794 | glycogen metabolism | 80 | 4 of 5 | ||
| 66794 | peptidoglycan biosynthesis | 80 | 12 of 15 | ||
| 66794 | ketogluconate metabolism | 75 | 6 of 8 | ||
| 66794 | C4 and CAM-carbon fixation | 75 | 6 of 8 | ||
| 66794 | flavin biosynthesis | 73.33 | 11 of 15 | ||
| 66794 | cardiolipin biosynthesis | 71.43 | 5 of 7 | ||
| 66794 | photosynthesis | 71.43 | 10 of 14 | ||
| 66794 | degradation of sugar alcohols | 68.75 | 11 of 16 | ||
| 66794 | valine metabolism | 66.67 | 6 of 9 | ||
| 66794 | acetoin degradation | 66.67 | 2 of 3 | ||
| 66794 | L-lactaldehyde degradation | 66.67 | 2 of 3 | ||
| 66794 | NAD metabolism | 66.67 | 12 of 18 | ||
| 66794 | formaldehyde oxidation | 66.67 | 2 of 3 | ||
| 66794 | glycolysis | 64.71 | 11 of 17 | ||
| 66794 | d-xylose degradation | 63.64 | 7 of 11 | ||
| 66794 | pentose phosphate pathway | 63.64 | 7 of 11 | ||
| 66794 | pyrimidine metabolism | 62.22 | 28 of 45 | ||
| 66794 | propanol degradation | 57.14 | 4 of 7 | ||
| 66794 | purine metabolism | 56.38 | 53 of 94 | ||
| 66794 | serine metabolism | 55.56 | 5 of 9 | ||
| 66794 | alanine metabolism | 55.17 | 16 of 29 | ||
| 66794 | phenylalanine metabolism | 53.85 | 7 of 13 | ||
| 66794 | ethanol fermentation | 50 | 1 of 2 | ||
| 66794 | cis-vaccenate biosynthesis | 50 | 1 of 2 | ||
| 66794 | sulfopterin metabolism | 50 | 2 of 4 | ||
| 66794 | dolichol and dolichyl phosphate biosynthesis | 50 | 1 of 2 | ||
| 66794 | phenylmercury acetate degradation | 50 | 1 of 2 | ||
| 66794 | gluconeogenesis | 50 | 4 of 8 | ||
| 66794 | adipate degradation | 50 | 1 of 2 | ||
| 66794 | degradation of pentoses | 50 | 14 of 28 | ||
| 66794 | non-pathway related | 47.37 | 18 of 38 | ||
| 66794 | oxidative phosphorylation | 47.25 | 43 of 91 | ||
| 66794 | d-mannose degradation | 44.44 | 4 of 9 | ||
| 66794 | reductive acetyl coenzyme A pathway | 42.86 | 3 of 7 | ||
| 66794 | glutamate and glutamine metabolism | 42.86 | 12 of 28 | ||
| 66794 | tetrahydrofolate metabolism | 42.86 | 6 of 14 | ||
| 66794 | mevalonate metabolism | 42.86 | 3 of 7 | ||
| 66794 | degradation of aromatic, nitrogen containing compounds | 41.67 | 5 of 12 | ||
| 66794 | arachidonate biosynthesis | 40 | 2 of 5 | ||
| 66794 | metabolism of amino sugars and derivatives | 40 | 2 of 5 | ||
| 66794 | threonine metabolism | 40 | 4 of 10 | ||
| 66794 | lipoate biosynthesis | 40 | 2 of 5 | ||
| 66794 | Entner Doudoroff pathway | 40 | 4 of 10 | ||
| 66794 | lipid metabolism | 38.71 | 12 of 31 | ||
| 66794 | urea cycle | 38.46 | 5 of 13 | ||
| 66794 | 6-hydroxymethyl-dihydropterin diphosphate biosynthesis | 37.5 | 3 of 8 | ||
| 66794 | isoleucine metabolism | 37.5 | 3 of 8 | ||
| 66794 | cyanate degradation | 33.33 | 1 of 3 | ||
| 66794 | enterobactin biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | acetyl CoA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | octane oxidation | 33.33 | 1 of 3 | ||
| 66794 | selenocysteine biosynthesis | 33.33 | 2 of 6 | ||
| 66794 | glycolate and glyoxylate degradation | 33.33 | 2 of 6 | ||
| 66794 | sphingosine metabolism | 33.33 | 2 of 6 | ||
| 66794 | IAA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | methionine metabolism | 30.77 | 8 of 26 | ||
| 66794 | leucine metabolism | 30.77 | 4 of 13 | ||
| 66794 | starch degradation | 30 | 3 of 10 | ||
| 66794 | glycine metabolism | 30 | 3 of 10 | ||
| 66794 | arginine metabolism | 29.17 | 7 of 24 | ||
| 66794 | ubiquinone biosynthesis | 28.57 | 2 of 7 | ||
| 66794 | tyrosine metabolism | 28.57 | 4 of 14 | ||
| 66794 | degradation of hexoses | 27.78 | 5 of 18 | ||
| 66794 | histidine metabolism | 27.59 | 8 of 29 | ||
| 66794 | metabolism of disaccharids | 27.27 | 3 of 11 | ||
| 66794 | proline metabolism | 27.27 | 3 of 11 | ||
| 66794 | vitamin B6 metabolism | 27.27 | 3 of 11 | ||
| 66794 | isoprenoid biosynthesis | 26.92 | 7 of 26 | ||
| 66794 | carnitine metabolism | 25 | 2 of 8 | ||
| 66794 | glycogen biosynthesis | 25 | 1 of 4 | ||
| 66794 | lactate fermentation | 25 | 1 of 4 | ||
| 66794 | butanoate fermentation | 25 | 1 of 4 | ||
| 66794 | CMP-KDO biosynthesis | 25 | 1 of 4 | ||
| 66794 | cyclohexanol degradation | 25 | 1 of 4 | ||
| 66794 | tryptophan metabolism | 23.68 | 9 of 38 | ||
| 66794 | ascorbate metabolism | 22.73 | 5 of 22 | ||
| 66794 | nitrate assimilation | 22.22 | 2 of 9 | ||
| 66794 | cysteine metabolism | 22.22 | 4 of 18 | ||
| 66794 | CO2 fixation in Crenarchaeota | 22.22 | 2 of 9 | ||
| 66794 | lipid A biosynthesis | 22.22 | 2 of 9 | ||
| 66794 | chorismate metabolism | 22.22 | 2 of 9 | ||
| 66794 | glutathione metabolism | 21.43 | 3 of 14 | ||
| 66794 | lysine metabolism | 21.43 | 9 of 42 |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17627 | - | - | - | - | + | + | + | - | - | - | - | + | + | +/- | - | - | - | - | - | - | - | - | +/- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | +/- | - | - |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Infection | #Patient | - | |
| #Host Body Product | #Gastrointestinal tract | #Feces (Stool) | |
| #Host | #Human | #Female |
Global distribution of 16S sequence LC519995 (>99% sequence identity) for Lentilactobacillus senioris subclade from Microbeatlas ![]()
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 67770 | ASM143655v1 assembly for Lentilactobacillus senioris DSM 24302 = JCM 17472 | scaffold | 1423802 | 75.62 | ||||
| 67770 | ASM131206v1 assembly for Lentilactobacillus senioris DSM 24302 = JCM 17472 | contig | 1423802 | 45.03 |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | spore_formation | BacteriaNetⓘ | yes | 62.80 | no |
| 125439 | motility | BacteriaNetⓘ | yes | 70.00 | no |
| 125439 | gram_stain | BacteriaNetⓘ | positive | 73.50 | no |
| 125439 | oxygen_tolerance | BacteriaNetⓘ | obligate aerobe | 99.50 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | yes | 93.68 | yes |
| 125438 | anaerobic | anaerobicⓘ | no | 85.84 | yes |
| 125438 | spore-forming | spore-formingⓘ | no | 91.95 | yes |
| 125438 | aerobic | aerobicⓘ | no | 96.67 | yes |
| 125438 | thermophilic | thermophileⓘ | no | 95.50 | yes |
| 125438 | flagellated | motile2+ⓘ | no | 90.50 | yes |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Effects of fermented soymilk with Lacticaseibacillus paracasei YIT 9029 on gut microbiota and defecation habits: a randomised, double-blind, placebo-controlled study. | Kaga C, Nagino T, Gomi A, Takagi A, Miyazaki K, Yoshida Y, Shida K. | Benef Microbes | 10.1163/18762891-bja00003 | 2024 | ||
| Structural determination of the cell wall polysaccharide LCPS-1 in Lacticaseibacillus paracasei strain Shirota YIT 9029. | Mizukoshi H, Kimura K, Ikemura H, Mori Y, Nagaoka M. | Carbohydr Res | 10.1016/j.carres.2022.108670 | 2022 | ||
| Evaluation of the cariogenic potential of a probiotic candidate strain Lactobacillus gasseri YIT 12321. | Okada A, Imai S, Kikuchi T, Matin K, Otsuka R, Terai T, Okumura T, Yamamoto T, Hanada N. | Arch Oral Biol | 10.1016/j.archoralbio.2022.105364 | 2022 | ||
| Genetics | Safety assessment of the candidate oral probiotic Lactobacillus crispatus YIT 12319: Analysis of antibiotic resistance and virulence-associated genes. | Terai T, Kato K, Ishikawa E, Nakao M, Ito M, Miyazaki K, Kushiro A, Imai S, Nomura Y, Hanada N, Okumura T. | Food Chem Toxicol | 10.1016/j.fct.2020.111278 | 2020 | |
| Metabolism | Bifidobacterium bifidum YIT 10347 fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms in healthy adults: A double-blind, randomized, placebo-controlled study. | Gomi A, Yamaji K, Watanabe O, Yoshioka M, Miyazaki K, Iwama Y, Urita Y. | J Dairy Sci | 10.3168/jds.2017-13803 | 2018 | |
| Glycophenotyping of mutants of Lacticaseibacillus paracasei by lectin microarray. | Suzuki E, Serata M, Sako T, Sato S, Iino T, Tateno H, Hirabayashi J. | Appl Environ Microbiol | 10.1128/aem.01707-24 | 2025 | ||
| Probiotics and other adjuvants in allergen-specific immunotherapy for food allergy: a comprehensive review. | Mennini M, Piccirillo M, Furio S, Valitutti F, Ferretti A, Strisciuglio C, De Filippo M, Parisi P, Peroni DG, Di Nardo G, Ferrari F. | Front Allergy | 10.3389/falgy.2024.1473352 | 2024 | ||
| Metabolism | Citrus juice fermented with Lactobacillus plantarum YIT 0132 alleviates symptoms of perennial allergic rhinitis in a double-blind, placebo-controlled trial. | Harima-Mizusawa N, Kano M, Nozaki D, Nonaka C, Miyazaki K, Enomoto T. | Benef Microbes | 10.3920/bm2016.0003 | 2016 | |
| Enzymology | Living cells of probiotic Bifidobacterium bifidum YIT 10347 detected on gastric mucosa in humans. | Shibahara-Sone H, Gomi A, Iino T, Kano M, Nonaka C, Watanabe O, Miyazaki K, Ohkusa T. | Benef Microbes | 10.3920/bm2015.0138 | 2016 | |
| The Efficacy of Probiotics Supplementation on the Quality of Life of Patients with Gastrointestinal Disease: A Systematic Review of Clinical Studies. | Moludi J, Saber A, Zozani MA, Moradi S, Azamian Y, Hajiahmadi S, Pasdar Y, Moradi F. | Prev Nutr Food Sci | 10.3746/pnf.2024.29.3.237 | 2024 | ||
| Metabolism | Health benefits of fermented milk containing Bifidobacterium bifidum YIT 10347 on gastric symptoms in adults. | Gomi A, Iino T, Nonaka C, Miyazaki K, Ishikawa F. | J Dairy Sci | 10.3168/jds.2014-9158 | 2015 | |
| Physiological, Pathological, and Circadian Factors Impacting Skin Hydration. | Camilion JV, Khanna S, Anasseri S, Laney C, Mayrovitz HN. | Cureus | 10.7759/cureus.27666 | 2022 | ||
| Production of angiotensin-I-converting enzyme (ACE) inhibitory activity in milk fermented with probiotic strains: Effects of calcium, pH and peptides on the ACE-inhibitory activity | Gonzalez-Gonzalez CR, Tuohy KM, Jauregi P. | Int Dairy J | 10.1016/j.idairyj.2011.04.001 | 2011 | ||
| Detection of Glycolytically Active Lacticaseibacillus paracasei Strain Shirota by Flow Cytometry Targeting the Efflux Activity of Fluorescent Dye: a Potential Tool for Quality Assessment of Probiotic Cells in Milk Products. | Kubota H, Serata M, Matsumoto H, Shida K, Okumura T. | Appl Environ Microbiol | 10.1128/aem.02156-22 | 2023 | ||
| Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer. | Miyake M, Oda Y, Owari T, Iida K, Ohnishi S, Fujii T, Nishimura N, Miyamoto T, Shimizu T, Ohnishi K, Hori S, Morizawa Y, Gotoh D, Nakai Y, Torimoto K, Tanaka N, Fujimoto K. | Cancer Sci | 10.1111/cas.15666 | 2023 | ||
| Membrane Emulsification as an Emerging Method for Lacticaseibacillus rhamnosus GG® Encapsulation. | Camelo-Silva C, Figueredo LL, Cesca K, Verruck S, Ambrosi A, Di Luccio M. | Food Bioproc Tech | 10.1007/s11947-023-03099-w | 2023 | ||
| Side-chain structure of cell surface polysaccharide, mannan, affects hypocholesterolemic activity of yeast. | Yoshida Y, Naito E, Mizukoshi H, Watanabe Y, Kimura K, Yokoi W, Sato T, Okumura T, Ito M, Sawada H. | J Agric Food Chem | 10.1021/jf900347q | 2009 | ||
| Peptide Extracts from Cultures of Certain Lactobacilli Inhibit Helicobacter pylori. | De Vuyst L, Vincent P, Makras E, Leroy F, Pot B. | Probiotics Antimicrob Proteins | 10.1007/s12602-009-9029-4 | 2010 | ||
| Effects of Fermented Milk Containing Lacticaseibacillus paracasei Strain Shirota on Constipation in Patients with Depression: A Randomized, Double-Blind, Placebo-Controlled Trial. | Zhang X, Chen S, Zhang M, Ren F, Ren Y, Li Y, Liu N, Zhang Y, Zhang Q, Wang R. | Nutrients | 10.3390/nu13072238 | 2021 | ||
| Effect of Lacticaseibacillus paracasei Strain Shirota on Improvement in Depressive Symptoms, and Its Association with Abundance of Actinobacteria in Gut Microbiota. | Otaka M, Kikuchi-Hayakawa H, Ogura J, Ishikawa H, Yomogida Y, Ota M, Hidese S, Ishida I, Aida M, Matsuda K, Kawai M, Yoshida S, Kunugi H. | Microorganisms | 10.3390/microorganisms9051026 | 2021 | ||
| A randomized, double blind, parallel, placebo-controlled study to investigate the efficacy of Lactobacillus paracasei N1115 in gut development of young children. | Wang S, Xun Y, Ahern GJ, Feng L, Zhang D, Xue Y, Ross RP, Doolan AM, Stanton C, Zhu H. | Food Sci Nutr | 10.1002/fsn3.2533 | 2021 | ||
| Effects of citrus juice fermented with Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis during probiotic consumption: an open study. | Kakiyama S, Kubota N, Shida K, Harima-Mizusawa N. | Biosci Microbiota Food Health | 10.12938/bmfh.2019-017 | 2020 | ||
| [The electron microscopic study of cell-to-cell interactions between antagonistic microorganisms]. | Rybal'chenko OV. | Mikrobiologiia | 10.1134/s0026261706040187 | 2006 | ||
| Effect of Kluyveromyces marxianus YIT 8292 crude cell wall fraction on serum lipids in normocholesterolemic and mildly hypercholesterolemic subjects. | Yoshida Y, Naito E, Ohishi K, Okumura T, Ito M, Sato T, Sawada H. | Biosci Biotechnol Biochem | 10.1271/bbb.60539 | 2007 | ||
| Role of Gastric Microorganisms Other than Helicobacter pylori in the Development and Treatment of Gastric Diseases. | Duan X, Chen P, Xu X, Han M, Li J. | Biomed Res Int | 10.1155/2022/6263423 | 2022 | ||
| Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials. | Zeng L, Yang K, He Q, Zhu X, Long Z, Wu Y, Chen J, Li Y, Zeng J, Cui G, Xiang W, Hao W, Sun L. | BMC Med | 10.1186/s12916-024-03303-4 | 2024 | ||
| Probiotics-induced changes in gut microbial composition and its effects on cognitive performance after stress: exploratory analyses. | Bloemendaal M, Szopinska-Tokov J, Belzer C, Boverhoff D, Papalini S, Michels F, van Hemert S, Arias Vasquez A, Aarts E. | Transl Psychiatry | 10.1038/s41398-021-01404-9 | 2021 | ||
| Effect of Bifidobacterium bifidum fermented milk on Helicobacter pylori and serum pepsinogen levels in humans. | Miki K, Urita Y, Ishikawa F, Iino T, Shibahara-Sone H, Akahoshi R, Mizusawa S, Nose A, Nozaki D, Hirano K, Nonaka C, Yokokura T. | J Dairy Sci | 10.3168/jds.2006-803 | 2007 | ||
| Effects of the cell wall of Kluyveromyces marxianus YIT 8292 on the plasma cholesterol and fecal sterol excretion in rats fed on a high-cholesterol diet. | Yoshida Y, Yokoi W, Ohishi K, Ito M, Naito E, Sawada H. | Biosci Biotechnol Biochem | 10.1271/bbb.69.714 | 2005 | ||
| Potent hypocholesterolemic activity of the yeast Kluyveromyces marxianus YIT 8292 in rats fed a high cholesterol diet. | Yoshida Y, Yokoi W, Wada Y, Ohishi K, Ito M, Sawada H. | Biosci Biotechnol Biochem | 10.1271/bbb.68.1185 | 2004 | ||
| Gastroesophageal Reflux Disease and Probiotics: A Systematic Review. | Cheng J, Ouwehand AC. | Nutrients | 10.3390/nu12010132 | 2020 | ||
| Probiotics for the Prevention of Acute Respiratory-Tract Infections in Older People: Systematic Review. | Strauss M, Micetic-Turk D, Pogacar MS, Fijan S. | Healthcare (Basel) | 10.3390/healthcare9060690 | 2021 | ||
| Neurogenic Bowel and Management after Spinal Cord Injury: A Narrative Review. | Rodriguez GM, Gater DR. | J Pers Med | 10.3390/jpm12071141 | 2022 | ||
| Pathogenicity | Partial purification and characterization of the bacteriocin produced by Lactobacillus acidophilus YIT 0154. | Yamato M, Ozaki K, Ota F. | Microbiol Res | 10.1078/0944-5013-00190 | 2003 | |
| Microencapsulation of Lactobacillus casei YIT 9018 using a Microporous Glass Membrane Emulsification System | Song SH, Cho YH, Park J. | J Food Sci | 10.1111/j.1365-2621.2003.tb14139.x | 2003 | ||
| Yogurt, cultured fermented milk, and health: a systematic review. | Savaiano DA, Hutkins RW. | Nutr Rev | 10.1093/nutrit/nuaa013 | 2021 | ||
| Critical roles of a housekeeping sortase of probiotic Bifidobacterium bifidum in bacterium-host cell crosstalk. | Ishikawa E, Yamada T, Yamaji K, Serata M, Fujii D, Umesaki Y, Tsuji H, Nomoto K, Ito M, Okada N, Nagaoka M, Gomi A. | iScience | 10.1016/j.isci.2021.103363 | 2021 | ||
| Biological and Cosmetical Importance of Fermented Raw Materials: An Overview. | Majchrzak W, Motyl I, Smigielski K. | Molecules | 10.3390/molecules27154845 | 2022 | ||
| Molecular Mechanism and Clinical Effects of Probiotics in the Management of Cow's Milk Protein Allergy. | Cela L, Brindisi G, Gravina A, Pastore F, Semeraro A, Bringheli I, Marchetti L, Morelli R, Cinicola B, Capponi M, Gori A, Pignataro E, Piccioni MG, Zicari AM, Anania C. | Int J Mol Sci | 10.3390/ijms24129781 | 2023 | ||
| Microbiome in atopic dermatitis. | Wollina U. | Clin Cosmet Investig Dermatol | 10.2147/ccid.s130013 | 2017 | ||
| Antimicrobial potential of probiotic lactic acid bacteria. | Avonts L, De Vuyst L. | Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet | 2001 | |||
| Pathogenicity | Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study. | Kanazawa A, Aida M, Yoshida Y, Kaga H, Katahira T, Suzuki L, Tamaki S, Sato J, Goto H, Azuma K, Shimizu T, Takahashi T, Yamashiro Y, Watada H. | Nutrients | 10.3390/nu13020558 | 2021 | |
| Probiotics as a Tool for Regulating Molecular Mechanisms in Depression: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. | Sikorska M, Antosik-Wojcinska AZ, Dominiak M. | Int J Mol Sci | 10.3390/ijms24043081 | 2023 | ||
| Metabolism | Production of menaquinones by lactic acid bacteria. | Morishita T, Tamura N, Makino T, Kudo S. | J Dairy Sci | 10.3168/jds.s0022-0302(99)75424-x | 1999 | |
| Effect of probiotic and prebiotic fermented milk on skin and intestinal conditions in healthy young female students. | Mori N, Kano M, Masuoka N, Konno T, Suzuki Y, Miyazaki K, Ueki Y. | Biosci Microbiota Food Health | 10.12938/bmfh.2015-022 | 2016 | ||
| Fermented Food in Asthma and Respiratory Allergies-Chance or Failure? | Debinska A, Sozanska B. | Nutrients | 10.3390/nu14071420 | 2022 | ||
| Enhancement of host resistance to bacterial infections in normal and immunosuppressed mice with Actinobacillus suis. | Watanabe T. | Kansenshogaku Zasshi | 10.11150/kansenshogakuzasshi1970.70.574 | 1996 | ||
| Metabolism | Transcriptomics reveal different metabolic strategies for acid resistance and gamma-aminobutyric acid (GABA) production in select Levilactobacillus brevis strains. | Banerjee S, Poore M, Gerdes S, Nedveck D, Lauridsen L, Kristensen HT, Jensen HM, Byrd PM, Ouwehand AC, Patterson E, Morovic W. | Microb Cell Fact | 10.1186/s12934-021-01658-4 | 2021 | |
| Microencapsulation of Lactobacillus plantarum DKL 109 using External Ionic Gelation Method. | Chun H, Kim CH, Cho YH. | Korean J Food Sci Anim Resour | 10.5851/kosfa.2014.34.5.692 | 2014 | ||
| Effect of Supplementation with Saccharomyces Boulardii on Academic Examination Performance and Related Stress in Healthy Medical Students: A Randomized, Double-Blind, Placebo-Controlled Trial. | Karbownik MS, Kreczynska J, Kwarta P, Cybula M, Wiktorowska-Owczarek A, Kowalczyk E, Pietras T, Szemraj J. | Nutrients | 10.3390/nu12051469 | 2020 | ||
| Consecutive Intake of Fermented Milk Containing Bifidobacterium breve Strain Yakult and Galacto-oligosaccharides Benefits Skin Condition in Healthy Adult Women. | Kano M, Masuoka N, Kaga C, Sugimoto S, Iizuka R, Manabe K, Sone T, Oeda K, Nonaka C, Miyazaki K, Ishikawa F. | Biosci Microbiota Food Health | 10.12938/bmfh.32.33 | 2013 | ||
| Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. | Kato I, Endo K, Yokokura T. | Int J Immunopharmacol | 10.1016/0192-0561(94)90116-3 | 1994 | ||
| Pathogenicity | Bifidobacteria Prevent Tunicamycin-Induced Endoplasmic Reticulum Stress and Subsequent Barrier Disruption in Human Intestinal Epithelial Caco-2 Monolayers. | Akiyama T, Oishi K, Wullaert A. | PLoS One | 10.1371/journal.pone.0162448 | 2016 | |
| Distribution of TNF endogenously induced by various immunopotentiators and Lactobacillus casei in mice. | Sakagami H, Kuroiwa Y, Takeda M, Ota H, Kazama K, Naoe T, Kawazoe Y, Ichikawa S, Kondo H, Yokokura T. | In Vivo | 1992 | |||
| Beneficial Effects of Citrus Juice Fermented with Lactobacillus plantarum YIT 0132 on Japanese Cedar Pollinosis. | Harima-Mizusawa N, Iino T, Onodera-Masuoka N, Kato-Nagaoka N, Kiyoshima-Shibata J, Gomi A, Shibahara-Sone H, Kano M, Shida K, Sakai M, Miyazaki K, Ishikawa F. | Biosci Microbiota Food Health | 10.12938/bmfh.33.147 | 2014 | ||
| Primary resistance induced in mice by Lactobacillus casei following infection with herpes simplex virus. | Watanabe T, Yamori T. | Kansenshogaku Zasshi | 10.11150/kansenshogakuzasshi1970.63.182 | 1989 | ||
| Structural studies of cell wall polysaccharides from Bifidobacterium breve YIT 4010 and related Bifidobacterium species. | Habu Y, Nagaoka M, Yokokura T, Azuma I. | J Biochem | 10.1093/oxfordjournals.jbchem.a122188 | 1987 | ||
| Protective effect of lipoteichoic acid from Lactobacillus casei and Lactobacillus fermentum against Pseudomonas aeruginosa in mice. | Setoyama T, Nomoto K, Yokokura T, Mutai M. | J Gen Microbiol | 10.1099/00221287-131-9-2501 | 1985 | ||
| Beneficial effects of citrus juice fermented with Lactobacillus plantarum YIT 0132 on atopic dermatitis: results of daily intake by adult patients in two open trials. | Harima-Mizusawa N, Kamachi K, Kano M, Nozaki D, Uetake T, Yokomizo Y, Nagino T, Tanaka A, Miyazaki K, Nakamura S. | Biosci Microbiota Food Health | 10.12938/bmfh.2015-010 | 2016 | ||
| Role of colony-stimulating activity in antitumor activity of Lactobacillus casei in mice. | Shimizu T, Nomoto K, Yokokura T, Mutai M. | J Leukoc Biol | 10.1002/jlb.42.3.204 | 1987 | ||
| [Antitumor activity of Lactobacillus casei YIT 9018 (LC 9018)--effect of administration route]. | Yokokura T, Kato I, Matsuzaki T, Mutai M, Satoh H. | Gan To Kagaku Ryoho | 1984 | |||
| Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC 9018) in combination with inactivated viral antigen. | Watanabe T, Saito H. | Microbiol Immunol | 10.1111/j.1348-0421.1986.tb00926.x | 1986 | ||
| Enzymology | The role of superoxide anion and lysosomal enzymes in anti-listerial activity of elicited peritoneal macrophages. | Hashimoto S, Nomoto K, Yokokura T. | Scand J Immunol | 10.1111/j.1365-3083.1986.tb02131.x | 1986 | |
| Biotechnology | Rapid Evaluation and Optimization of Medium Components Governing Tryptophan Production by Pediococcus acidilactici TP-6 Isolated from Malaysian Food via Statistical Approaches. | Lim YH, Foo HL, Loh TC, Mohamad R, Abdul Rahim R. | Molecules | 10.3390/molecules25040779 | 2020 | |
| Metabolism | Optimized medium via statistical approach enhanced threonine production by Pediococcus pentosaceus TL-3 isolated from Malaysian food. | Lim YH, Foo HL, Loh TC, Mohamad R, Abdul Rahim R, Idrus Z. | Microb Cell Fact | 10.1186/s12934-019-1173-2 | 2019 | |
| Effects of Lactobacillus casei on Pseudomonas aeruginosa infection in normal and dexamethasone-treated mice. | Saito H, Watanabe T, Horikawa Y. | Microbiol Immunol | 10.1111/j.1348-0421.1986.tb00940.x | 1986 | ||
| Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei. | Nomoto K, Miake S, Hashimoto S, Yokokura T, Mutai M, Yoshikai Y, Nomoto K. | J Clin Lab Immunol | 1985 | |||
| Induction of tumoricidal peritoneal exudate cells by administration of Lactobacillus casei. | Kato I, Yokokura T, Mutai M. | Int J Immunopharmacol | 10.1016/0192-0561(85)90015-3 | 1985 | ||
| Host-mediated antitumor activity of Lactobacillus casei in mice. | Yasutake N, Kato I, Ohwaki M, Yokokura T, Mutai M. | Gan | 1984 | |||
| [Augmentation of antitumor activity of Lactobacillus casei YIT 8018 (LC 9018) in combination with various antitumor drugs]. | Matsuzaki T, Kato I, Yokokura T, Mutai M. | Gan To Kagaku Ryoho | 1984 | |||
| Macrophage activation by Lactobacillus casei in mice. | Kato I, Yokokura T, Mutai M. | Microbiol Immunol | 10.1111/j.1348-0421.1983.tb00622.x | 1983 | ||
| Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens. | Kato I, Yokokura T, Mutai M. | Microbiol Immunol | 10.1111/j.1348-0421.1984.tb00672.x | 1984 | ||
| Metabolism | In vitro binding of potent mutagenic pyrolysates to intestinal bacteria. | Morotomi M, Mutai M. | J Natl Cancer Inst | 10.1093/jnci/77.1.195 | 1986 | |
| Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators. | Yasutake N, Ohwaki M, Yokokura T, Mutai M. | Med Microbiol Immunol | 10.1007/bf02123760 | 1984 | ||
| Kinetic modeling, production and characterization of an acidic lipase produced by Enterococcus durans NCIM5427 from fish waste. | Ramakrishnan V, Goveas LC, Halami PM, Narayan B. | J Food Sci Technol | 10.1007/s13197-013-1141-5 | 2015 | ||
| Antitumor activity of Lactobacillus casei in mice. | Kato I, Kobayashi S, Yokokura T, Mutai M. | Gan | 1981 | |||
| Enzymology | Screening of Probiotic Candidates in Human Oral Bacteria for the Prevention of Dental Disease. | Terai T, Okumura T, Imai S, Nakao M, Yamaji K, Ito M, Nagata T, Kaneko K, Miyazaki K, Okada A, Nomura Y, Hanada N. | PLoS One | 10.1371/journal.pone.0128657 | 2015 | |
| Metabolism | Lectin microarray reveals binding profiles of Lactobacillus casei strains in a comprehensive analysis of bacterial cell wall polysaccharides. | Yasuda E, Tateno H, Hirabayashi J, Iino T, Sako T. | Appl Environ Microbiol | 10.1128/aem.00240-11 | 2011 | |
| Brain-gut axis in the pathogenesis of Helicobacter pylori infection. | Budzynski J, Budzynski J, Klopocka M. | World J Gastroenterol | 10.3748/wjg.v20.i18.5212 | 2014 | ||
| Optimizing conditions for the growth of Lactobacillus casei YIT 9018 in tryptone-yeast extract-glucose medium by using response surface methodology. | Oh S, Rheem S, Sim J, Kim S, Baek Y. | Appl Environ Microbiol | 10.1128/aem.61.11.3809-3814.1995 | 1995 | ||
| Enzymology | Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. | Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. | Appl Environ Microbiol | 10.1128/aem.70.12.7220-7228.2004 | 2004 | |
| Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice. | Kato I, Yokokura T, Mutai M. | Cancer Immunol Immunother | 10.1007/bf00199932 | 1988 | ||
| Antitumor effect of intrapleural administration of Lactobacillus casei in mice. | Matsuzaki T, Yokokura T, Mutai M. | Cancer Immunol Immunother | 10.1007/bf00199931 | 1988 | ||
| Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. | Matsuzaki T, Yokokura T, Azuma I. | Cancer Immunol Immunother | 10.1007/bf00199768 | 1985 | ||
| Enzymology | Structure of macroamphiphiles from several Bifidobacterium strains. | Iwasaki H, Araki Y, Ito E, Nagaoka M, Yokokura T. | J Bacteriol | 10.1128/jb.172.2.845-852.1990 | 1990 | |
| Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation. | Nomoto K, Yokokura T, Mitsuyama M, Yoshikai Y, Nomoto K. | Antimicrob Agents Chemother | 10.1128/aac.36.2.361 | 1992 | ||
| In vitro and in vivo release of cytostatic factors from Lactobacillus casei-elicited peritoneal macrophages after stimulation with tumor cells and immunostimulants. | Hashimoto S, Nomoto K, Nagaoka M, Yokokura T. | Cancer Immunol Immunother | 10.1007/bf00199825 | 1987 | ||
| Anti-tumour effect of humoral and cellular immunities mediated by a bacterial immunopotentiator, Lactobacillus casei, in mice. | Yasutake N, Ohwaki M, Mutai M, Koide Y, Yoshida T. | Cancer Immunol Immunother | 10.1007/bf00205676 | 1985 | ||
| Antimicrobial Resistance of Lactic Acid Bacteria from Nono, a Naturally Fermented Milk Product. | Obioha PI, Anyogu A, Awamaria B, Ghoddusi HB, Ouoba LII. | Antibiotics (Basel) | 10.3390/antibiotics12050843 | 2023 | ||
| Phylogeny | Flavobacterium agri sp. nov., a novel bacterial species isolated from rhizospheric soil of Coriandrum sativum. | Akter S, Lee SY, Moon B, Huq MA. | Arch Microbiol | 10.1007/s00203-020-02068-7 | 2021 | |
| Phylogeny | Lentilactobacillus laojiaonis sp. nov., isolated from the mud in a fermentation cellar for the production of Chinese liquor. | Zhao Q, Yang S, Bao G, Wang W, Miao L, Wang S, Shen C, Li Y | Int J Syst Evol Microbiol | 10.1099/ijsem.0.005349 | 2022 | |
| Phylogeny | Lentilactobacillus kribbianus sp. nov., isolated from the small intestine of a mini pig. | Bai L, Paek J, Shin Y, Park HY, Chang YH | Int J Syst Evol Microbiol | 10.1099/ijsem.0.004560 | 2020 | |
| Phylogeny | Lactobacillus curieae sp. nov., isolated from stinky tofu brine. | Lei X, Sun G, Xie J, Wei D | Int J Syst Evol Microbiol | 10.1099/ijs.0.041830-0 | 2012 | |
| Phylogeny | Lactobacillus saniviri sp. nov. and Lactobacillus senioris sp. nov., isolated from human faeces. | Oki K, Kudo Y, Watanabe K | Int J Syst Evol Microbiol | 10.1099/ijs.0.031658-0 | 2011 |
| #17627 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 24302 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #26590 | IJSEM 601 2012 ( DOI 10.1099/ijs.0.031658-0 , PubMed 21515698 ) |
| #30248 | Barberan A, Caceres Velazquez H, Jones S, Fierer N.: Hiding in Plain Sight: Mining Bacterial Species Records for Phenotypic Trait Information. mSphere 2: 2017 ( DOI 10.1128/mSphere.00237-17 , PubMed 28776041 ) - originally annotated from #26590 |
| #66794 | Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg: BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49: D498 - D508 2020 ( DOI 10.1093/nar/gkaa1025 , PubMed 33211880 ) |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #68371 | Automatically annotated from API 50CH acid . |
| #69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive6702.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data